TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 53 filers reported holding TRANSLATE BIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $13,770,000 | -16.5% | 500,000 | -50.0% | 0.28% | -4.1% |
| Q1 2021 | $16,490,000 | -25.4% | 1,000,000 | -16.7% | 0.29% | -38.7% |
| Q4 2020 | $22,116,000 | +16.1% | 1,200,000 | -14.3% | 0.48% | +2.6% |
| Q3 2020 | $19,054,000 | -33.5% | 1,400,000 | -12.5% | 0.46% | -42.3% |
| Q2 2020 | $28,672,000 | +379.3% | 1,600,000 | +166.7% | 0.80% | +217.0% |
| Q1 2020 | $5,982,000 | +13.1% | 600,000 | -7.7% | 0.25% | +24.0% |
| Q4 2019 | $5,291,000 | -28.8% | 650,000 | -13.3% | 0.20% | -31.5% |
| Q3 2019 | $7,433,000 | -21.5% | 750,000 | 0.0% | 0.30% | -22.2% |
| Q2 2019 | $9,473,000 | +54.9% | 750,000 | +25.0% | 0.38% | +53.2% |
| Q1 2019 | $6,114,000 | +35.9% | 600,000 | 0.0% | 0.25% | +49.7% |
| Q4 2018 | $4,500,000 | -25.0% | 600,000 | 0.0% | 0.17% | +7.1% |
| Q3 2018 | $6,000,000 | -5.1% | 600,000 | +20.0% | 0.16% | +16.4% |
| Q2 2018 | $6,325,000 | – | 500,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,922,008 | $39,102,000 | 52.94% |
| Omega Fund Management, LLC | 2,437,603 | $24,303,000 | 10.06% |
| Baupost Group | 17,544,239 | $171,071,000 | 2.52% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $21,762,000 | 2.47% |
| RTW INVESTMENTS, LP | 3,692,424 | $36,813,000 | 1.58% |
| Camber Capital Management LP | 1,765,000 | $17,597,000 | 1.05% |
| Bain Capital Public Equity Management II, LLC | 416,670 | $4,154,000 | 0.49% |
| Rock Springs Capital Management LP | 825,000 | $8,225,000 | 0.34% |
| Birchview Capital, LP | 30,000 | $299,000 | 0.26% |
| Artal Group S.A. | 600,000 | $5,982,000 | 0.25% |